Literature DB >> 15084984

Enhanced angiogenesis due to inflammatory cytokines from pancreatic cancer cell lines and relation to metastatic potential.

Yoichi Matsuo1, Hirozumi Sawai, Hitoshi Funahashi, Hiroki Takahashi, Masaki Sakamoto, Minoru Yamamoto, Yuji Okada, Tetsushi Hayakawa, Tadao Manabe.   

Abstract

OBJECTIVES: To investigate the mechanisms of metastasis formation in human pancreatic carcinoma, we examined the angiogenic capabilities of human pancreatic cancer cell lines with different metastatic potentials and the roles of inflammatory cytokines.
METHODS: Interleukin (IL)-8 secretion by human pancreatic cancer cells stimulated with IL-1alpha or IL-1 receptor antagonist (IL-1ra) was measured by enzyme-linked immunosorbent assay (ELISA). We then examined how cancer cells with different metastatic potentials influenced the proliferation and tube formation of human umbilical vein endothelial cells (HUVECs) using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide dye reduction method (MTT assay) and an angiogenesis assay, respectively. We also examined the role of inflammatory cytokines in relation to tumor metastatic potential and angiogenesis.
RESULTS: IL-8 secretion levels by pancreatic cancer cells were regulated by IL-1alpha and correlated with metastatic potential. Both HUVEC proliferation and tube formation were strongly enhanced by coculture with metastatic pancreatic cancer cells and were enhanced to a similar extent by culture in the presence of IL-1alpha and IL-8. In contrast, blockade of IL-1alpha or IL-8 inhibited HUVEC proliferation and angiogenesis.
CONCLUSIONS: The inflammatory cytokines IL-1alpha and IL-8 may have an important role in metastasis via vascular endothelial cell proliferation and angiogenesis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15084984     DOI: 10.1097/00006676-200404000-00025

Source DB:  PubMed          Journal:  Pancreas        ISSN: 0885-3177            Impact factor:   3.327


  23 in total

1.  Interleukin-8, a promising predictor for prognosis of pancreatic cancer.

Authors:  Ying Chen; Min Shi; Guan-Zhen Yu; Xiao-Ran Qin; Gang Jin; Peng Chen; Ming-Hua Zhu
Journal:  World J Gastroenterol       Date:  2012-03-14       Impact factor: 5.742

2.  Up-regulation and sustained activation of Stat1 are essential for interferon-gamma (IFN-gamma)-induced dual oxidase 2 (Duox2) and dual oxidase A2 (DuoxA2) expression in human pancreatic cancer cell lines.

Authors:  Yongzhong Wu; Smitha Antony; Agnes Juhasz; Jiamo Lu; Yun Ge; Guojian Jiang; Krishnendu Roy; James H Doroshow
Journal:  J Biol Chem       Date:  2011-02-14       Impact factor: 5.157

Review 3.  Phenotype and genotype of pancreatic cancer cell lines.

Authors:  Emily L Deer; Jessica González-Hernández; Jill D Coursen; Jill E Shea; Josephat Ngatia; Courtney L Scaife; Matthew A Firpo; Sean J Mulvihill
Journal:  Pancreas       Date:  2010-05       Impact factor: 3.327

4.  Serum biomarker panel diagnostics in pancreatic ductal adenocarcinoma: the clinical utility of soluble interleukins, IFN-γ, TNF-α and PD-1/PD-L1 in comparison to established serum tumor markers.

Authors:  Klara Dorman; Miriam Gerckens; Stefan Boeck; Stefan Holdenrieder; Stephan Kruger; Kimberly Krueger; Zsuzsanna Mayer; Alexander Rupp; Danmei Zhang; Lena Weiss; C Benedikt Westphalen; Michael Haas; Michael Guenther; Steffen Ormanns; Frank Klawonn; Jens Werner; Michael von Bergwelt-Baildon; Volker Heinemann
Journal:  J Cancer Res Clin Oncol       Date:  2022-06-23       Impact factor: 4.553

5.  CCL20/CCR6 expression profile in pancreatic cancer.

Authors:  Claudia Rubie; Vilma Oliveira Frick; Pirus Ghadjar; Mathias Wagner; Henner Grimm; Benjamin Vicinus; Christoph Justinger; Stefan Graeber; Martin K Schilling
Journal:  J Transl Med       Date:  2010-05-10       Impact factor: 5.531

6.  Examination of apoptosis signaling in pancreatic cancer by computational signal transduction analysis.

Authors:  Felix Rückert; Gihan Dawelbait; Christof Winter; Arndt Hartmann; Axel Denz; Ole Ammerpohl; Michael Schroeder; Hans Konrad Schackert; Bence Sipos; Günter Klöppel; Holger Kalthoff; Hans-Detlev Saeger; Christian Pilarsky; Robert Grützmann
Journal:  PLoS One       Date:  2010-08-19       Impact factor: 3.240

Review 7.  Resolvins and omega three polyunsaturated fatty acids: Clinical implications in inflammatory diseases and cancer.

Authors:  Kazuki Moro; Masayuki Nagahashi; Rajesh Ramanathan; Kazuaki Takabe; Toshifumi Wakai
Journal:  World J Clin Cases       Date:  2016-07-16       Impact factor: 1.337

8.  Proteasome inhibitor MG132 inhibits angiogenesis in pancreatic cancer by blocking NF-kappaB activity.

Authors:  Yoichi Matsuo; Hirozumi Sawai; Nobuo Ochi; Akira Yasuda; Masaki Sakamoto; Hiroki Takahashi; Hitoshi Funahashi; Hiromitsu Takeyama; Sushovan Guha
Journal:  Dig Dis Sci       Date:  2009-04-28       Impact factor: 3.199

9.  Interleukin-8 increases vascular endothelial growth factor and neuropilin expression and stimulates ERK activation in human pancreatic cancer.

Authors:  Min Li; Yuqing Zhang; Louis W Feurino; Hao Wang; William E Fisher; F Charles Brunicardi; Changyi Chen; Qizhi Yao
Journal:  Cancer Sci       Date:  2008-02-27       Impact factor: 6.716

10.  Extracellular DNA in pancreatic cancer promotes cell invasion and metastasis.

Authors:  Fushi Wen; Alex Shen; Andrew Choi; Eugene W Gerner; Jiaqi Shi
Journal:  Cancer Res       Date:  2013-05-30       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.